- Home
- KPTI vs ANIX Comparison
KPTI vs ANIX Comparison
Compare KPTI & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | ANIX |
|---|---|---|
| Founded | 2008 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 104.0M |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KPTI | ANIX |
|---|---|---|
| Price | $7.16 | $2.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $14.67 | $8.67 |
| AVG Volume (30 Days) | ★ 1.2M | 87.7K |
| Earning Date | 05-11-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.82 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | $210,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.36 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.65 | $2.38 |
| 52 Week High | $10.99 | $5.46 |
Technical Indicators
Market Signals| Indicator | KPTI | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 51.44 | 46.02 |
| Support Level | $5.53 | $2.44 |
| Resistance Level | $7.81 | $3.10 |
| Average True Range (ATR) | 0.78 | 0.20 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 52.72 | 47.83 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.